Cargando…
A randomized, controlled trial of interferon-β-1a (Avonex(®)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]
The objective of this study was to evaluate the safety and possible efficacy of IFN-β-1a for the treatment of patients with rheumatoid arthritis (RA). Twenty-two patients with active RA were enrolled in a phase II randomized, double-blind, placebo-controlled trial of 30 μg IFN-β-1a by weekly self-in...
Autores principales: | Genovese, Mark C, Chakravarty, Eliza F, Krishnan, Eswar, Moreland, Larry W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400417/ https://www.ncbi.nlm.nih.gov/pubmed/14979940 http://dx.doi.org/10.1186/ar1026 |
Ejemplares similares
-
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021) -
Unmet needs in rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005) -
Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000) -
Interferon Beta-1a (AVONEX(®)) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
por: Kleinschnitz, Christoph, et al.
Publicado: (2015) -
Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS
por: Najafi, Behzad, et al.
Publicado: (2015)